a Division of Psychiatry , University College London , London , UK and.
b North East London NHS Foundation Trust, Research & Development department, Goodmayes Hospital , Essex , UK.
J Ment Health. 2018 Aug;27(4):322-328. doi: 10.1080/09638237.2017.1370637. Epub 2017 Aug 31.
Treatment decision-making that fully involves service users is an aim across medicine, including mental health.
To explore service users experiences of taking antipsychotic medication for psychotic disorders and their perceptions of decision-making about this.
Semi-structured interviews with 20 users of community mental health services, conducted by service user researchers and analysed using thematic analysis.
Antipsychotic medication was perceived to have beneficial effects on symptoms and relapse risk, but adverse effects were prominent, including a global state of lethargy and demotivation. Weighing these up, the majority viewed antipsychotics as the least worst option. Participants were split between positions of "willing acceptance", "resigned acceptance" and "non-acceptance" of taking antipsychotics. Many felt their choices about medication were limited, due to the nature of their illness or pressure from other people. They commonly experienced their prescribing psychiatrist as not sufficiently acknowledging the negative impacts of medication on life quality and physical health concerns and described feeling powerless to influence decisions about their medication.
The study highlights the complexity of agendas surrounding antipsychotic medication, including the pervasive influence of coercive processes and the challenges of implementing collaborative decision-making for people with serious mental health problems.
充分让服务使用者参与治疗决策是医学领域的目标,包括精神健康。
探索服务使用者在使用抗精神病药物治疗精神障碍方面的体验,以及他们对该治疗决策的看法。
通过服务用户研究人员进行半结构化访谈,对 20 名社区精神卫生服务使用者进行访谈,采用主题分析进行分析。
抗精神病药物被认为对症状和复发风险有有益的影响,但不良反应也很明显,包括整体的疲劳和动力不足状态。权衡这些因素后,大多数人认为抗精神病药物是最不糟糕的选择。参与者在“自愿接受”、“无奈接受”和“不接受”服用抗精神病药物之间存在分歧。许多人感到他们对药物的选择受到限制,原因是他们的疾病性质或来自其他人的压力。他们普遍感到他们的处方精神科医生没有充分认识到药物对生活质量和身体健康的负面影响,并描述了他们在影响自己药物治疗决策方面感到无能为力。
该研究强调了围绕抗精神病药物的各种复杂问题,包括强制性过程的普遍影响,以及对严重精神健康问题患者实施协作决策的挑战。